Turano, S. and Conforti, S. 2018. Long-term survival in a patient with metastatic HER2+ breast cancer undergoing lapatinib-based therapy for 6 years: Lunga sopravvivenza in una paziente con carcinoma mammario HER2-positivo metastatico in terapia da sei anni con lapatinib. AboutOpen. 4, 1 (Sep. 2018), 8–10. DOI:https://doi.org/10.19156/abtpn.2018.0032.